Survie Des Personnes Atteintes de Cancer à la Réunion, 1998-2008 (SUCRE)

Centre Hospitalier Universitaire de la Réunion1 site in 1 country18,000 target enrollmentJanuary 1, 2019

ConditionsNeoplasms

Overview

Phase: N/A
Intervention: Not specified
Conditions: Neoplasms
Sponsor: Centre Hospitalier Universitaire de la Réunion
Enrollment: 18000
Locations: 1
Primary Endpoint: 5 years related survival rate by cancer site and gender
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Detailed Description

Data are extracted from Reunion Island Cancer Registry.

Registry

clinicaltrials.gov

Start Date

January 1, 2019

End Date

December 31, 2019

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Centre Hospitalier Universitaire de la Réunion

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients domiciled in Reunion Island at diagnosis
•Patients with at least 15 years of age at diagnosis
•Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

Exclusion Criteria

•Cutaneous malignant cancer expected melanoma

Outcomes

Primary Outcomes

5 years related survival rate by cancer site and gender

Time Frame: 5 years

Secondary Outcomes

1, 3, 5 and 10 years related survival rate by cancer site and gender(1, 3, 5 and 10 years)
1, 3, 5 and 10 years related survival rate by age at diagnosis(1, 3, 5 and 10 years)
1, 3, 5 and 10 years standardised survival rate by cancer site and gender(1, 3, 5 and 10 years)